CVS Health Income After Taxes 2010-2024 | CVS
CVS Health annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- CVS Health income after taxes for the quarter ending December 31, 2024 was $1.623B, a 20.71% decline year-over-year.
- CVS Health income after taxes for the twelve months ending December 31, 2024 was $4.586B, a 45.2% decline year-over-year.
- CVS Health annual income after taxes for 2024 was $4.586B, a 45.2% decline from 2023.
- CVS Health annual income after taxes for 2023 was $8.368B, a 93.39% increase from 2022.
- CVS Health annual income after taxes for 2022 was $4.327B, a 45.84% decline from 2021.
| CVS Health Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $4,586 |
| 2023 | $8,368 |
| 2022 | $4,327 |
| 2021 | $7,989 |
| 2020 | $7,201 |
| 2019 | $6,631 |
| 2018 | $-596 |
| 2017 | $6,631 |
| 2016 | $5,320 |
| 2015 | $5,230 |
| 2014 | $4,645 |
| 2013 | $4,600 |
| 2012 | $3,869 |
| 2011 | $3,489 |
| 2010 | $3,422 |
| 2009 | $3,700 |
| CVS Health Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,623 |
| 2024-09-30 | $71 |
| 2024-06-30 | $1,768 |
| 2024-03-31 | $1,124 |
| 2023-12-31 | $2,047 |
| 2023-09-30 | $2,265 |
| 2023-06-30 | $1,914 |
| 2023-03-31 | $2,142 |
| 2022-12-31 | $2,332 |
| 2022-09-30 | $-3,399 |
| 2022-06-30 | $3,039 |
| 2022-03-31 | $2,355 |
| 2021-12-31 | $1,387 |
| 2021-09-30 | $1,587 |
| 2021-06-30 | $2,791 |
| 2021-03-31 | $2,224 |
| 2020-12-31 | $984 |
| 2020-09-30 | $1,219 |
| 2020-06-30 | $2,986 |
| 2020-03-31 | $2,012 |
| 2019-12-31 | $1,744 |
| 2019-09-30 | $1,529 |
| 2019-06-30 | $1,931 |
| 2019-03-31 | $1,427 |
| 2018-12-31 | $-422 |
| 2018-09-30 | $1,390 |
| 2018-06-30 | $-2,562 |
| 2018-03-31 | $998 |
| 2017-12-31 | $3,287 |
| 2017-09-30 | $1,285 |
| 2017-06-30 | $1,097 |
| 2017-03-31 | $962 |
| 2016-12-31 | $1,707 |
| 2016-09-30 | $1,542 |
| 2016-06-30 | $924 |
| 2016-03-31 | $1,147 |
| 2015-12-31 | $1,500 |
| 2015-09-30 | $1,237 |
| 2015-06-30 | $1,272 |
| 2015-03-31 | $1,221 |
| 2014-12-31 | $1,322 |
| 2014-09-30 | $948 |
| 2014-06-30 | $1,246 |
| 2014-03-31 | $1,129 |
| 2013-12-31 | $1,266 |
| 2013-09-30 | $1,255 |
| 2013-06-30 | $1,125 |
| 2013-03-31 | $954 |
| 2012-12-31 | $1,116 |
| 2012-09-30 | $1,011 |
| 2012-06-30 | $966 |
| 2012-03-31 | $776 |
| 2011-12-31 | $1,100 |
| 2011-09-30 | $867 |
| 2011-06-30 | $813 |
| 2011-03-31 | $709 |
| 2010-12-31 | $1,013 |
| 2010-09-30 | $815 |
| 2010-06-30 | $822 |
| 2010-03-31 | $772 |
| 2009-12-31 | $1,045 |
| 2009-09-30 | $1,023 |
| 2009-06-30 | $889 |
| 2009-03-31 | $743 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.108B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.654B | 26.76 |
| Elevance Health (ELV) | United States | $95.024B | 12.26 |
| Cencora (COR) | United States | $56.754B | 20.60 |
| Natera (NTRA) | United States | $20.404B | 0.00 |
| DiDi Global (DIDIY) | China | $19.733B | 29.00 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.474B | 0.00 |
| ICON (ICLR) | Ireland | $12.230B | 11.37 |
| Solventum (SOLV) | United States | $11.439B | 10.66 |
| CochLear (CHEOY) | Australia | $11.362B | 0.00 |
| Revvity (RVTY) | United States | $11.225B | 18.95 |
| Doximity (DOCS) | United States | $10.619B | 55.22 |
| Viatris (VTRS) | United States | $10.051B | 3.18 |
| Medpace Holdings (MEDP) | United States | $8.864B | 23.54 |
| Avantor (AVTR) | United States | $8.852B | 12.86 |
| Sonic Healthcare (SKHHY) | Australia | $8.023B | 0.00 |
| HealthEquity (HQY) | United States | $7.414B | 36.48 |
| Charles River Laboratories (CRL) | United States | $5.826B | 11.49 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.08 |
| Alignment Healthcare (ALHC) | United States | $3.503B | 0.00 |
| Organon (OGN) | United States | $3.361B | 3.39 |
| Sotera Health (SHC) | United States | $3.264B | 18.85 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.814B | 32.28 |
| Concentras Parent (CON) | United States | $2.788B | 14.50 |
| Progyny (PGNY) | United States | $1.957B | 43.09 |
| GeneDx Holdings (WGS) | United States | $1.876B | 73.46 |
| Premier (PINC) | United States | $1.858B | 11.90 |
| Ardent Health Partners (ARDT) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.776B | 38.58 |
| Agilon Health (AGL) | United States | $1.759B | 0.00 |
| PACS (PACS) | United States | $1.468B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.260B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.105B | 9.27 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $0.938B | 14.68 |
| Establishment Labs Holdings (ESTA) | $0.875B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 6.17 |
| Embecta (EMBC) | United States | $0.709B | 4.86 |
| Nutex Health (NUTX) | United States | $0.608B | 11.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.511B | 13.55 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 38.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.331B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| DocGo (DCGO) | United States | $0.227B | 9.29 |
| Oncology Institute (TOI) | United States | $0.187B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 5.95 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |